Join Paid Clinical Trials for Arthritis

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Arthritis

Top of Directory » All Categories » by Illness » Arthritis



  • OTIS Autoimmune Diseases in Pregnancy Project

    Conditions:   Ankylosing Spondylitis;   Psoriatic Arthritis;   Psoriasis;   Rheumatoid Arthritis
    Intervention:  
    Sponsors:   University of California, San Diego;   Organization of Teratology Information Specialists (OTIS);   Amgen
    Recruiting - verified November 2009
  • Study Evaluating the Efficacy and Safety of SBI-087 in Seropositive Subjects With Active Rheumatoid Arthritis

    Condition:   Active Rheumatoid Arthritis
    Intervention:   Drug: SBI-087
    Sponsor:   Wyeth
    Recruiting - verified November 2009
  • A Pharmacokinetic/Pharmacodynamic Study of Intravenous and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis on Methotrexate

    Conditions:   Arthritis;   Rheumatoid Arthritis
    Interventions:   Biological: CDP6038;   Biological: CDP6038;   Biological: CDP6038;   Biological: CDP6038;   Biological: CDP6038;   Biological: CDP6038;   Other: Placebo IV;   Other: Placebo SC
    Sponsor:   UCB, Inc.
    Recruiting - verified November 2009
  • Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants

    Condition:   Rheumatoid Arthritis
    Intervention:   Drug: Etanercept
    Sponsors:   University of Pittsburgh;   Amgen
    Recruiting - verified November 2009
  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009
  • Golimumab in Rheumatoid Arthritis Patients With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

    Conditions:   Arthritis;   Arthritis, Rheumatoid;   Autoimmune Diseases
    Interventions:   Drug: golimumab;   Drug: golimumab or placebo;   Drug: golimumab or placebo
    Sponsors:   Centocor, Inc.;   Schering-Plough
    Recruiting - verified November 2009
  • Conjoint Analysis of Treatment Preferences for Osteoarthritis

    Condition:   Osteoarthritis
    Interventions:   Behavioral: Standard of care for osteoarthritis treatment;   Behavioral: Conjoint Analysis for Osteoarthritis
    Sponsors:   Baylor College of Medicine;   Agency for Healthcare Research and Quality (AHRQ);   M.D. Anderson Cancer Center
    Recruiting - verified October 2009
  • The Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis to Assess the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

    Condition:   Rheumatoid Arthritis
    Interventions:   Biological: Placebo;   Biological: Certolizumab pegol
    Sponsor:   UCB, Inc.
    Recruiting - verified November 2009
  • A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

    Condition:   Juvenile Idiopathic Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: tocilizumab;   Drug: placebo;   Drug: NSAIDs, corticosteroids, methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009
  • Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

    Condition:   Gout
    Interventions:   Drug: placebo;   Drug: BCX4208
    Sponsor:   BioCryst Pharmaceuticals
    Recruiting - verified November 2009
  • A Study To Investigate Whether PF-04457845 Is Effective In Treating Pain, Is Safe And Tolerable In Patients With Osteoarthritis Of The Knee

    Condition:   Osteoarthritis, Knee
    Interventions:   Drug: PF-04457845;   Drug: PF-04457845;   Drug: Naproxen;   Drug: Naproxen
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Subjects With Pain Due to Osteoarthritis of the Knee

    Condition:   Osteoarthritis of the Knee
    Interventions:   Drug: ADL5859;   Drug: ADL5747;   Drug: Oxycodone CR;   Drug: Placebo
    Sponsors:   Adolor Corporation;   Pfizer
    Recruiting - verified November 2009
  • An Efficacy and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis (RA) Despite Treatment With Methotrexate, Non Steroidal Pain Medications and/or Corticosteroids

    Condition:   Arthritis, Rheumatoid
    Interventions:   Biological: golimumab;   Biological: golimumab;   Biological: golimumab;   Drug: placebo
    Sponsors:   Centocor, Inc.;   Schering-Plough
    Recruiting - verified November 2009
  • A Study in Patients With Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Biological: LY2439821;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009
  • A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain

    Conditions:   Osteoarthritis;   Osteoarthritis, Hip;   Osteoarthritis, Knee;   Pain;   Arthralgia;   Joint Pain
    Interventions:   Drug: JNJ-42160443;   Drug: Placebo;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009
  • Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

    Condition:   Arthritis, Rheumatoid
    Interventions:   Drug: CP-690,550;   Drug: CP-690,550;   Drug: Placebo;   Drug: CP-690,550;   Drug: Placebo;   Drug: CP-690,550
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Long-Term Study Of The Safety Of Tanezumab In Arthritis Patients

    Condition:   Osteoarthritis
    Interventions:   Biological: Tanezumab;   Biological: Tanezumab;   Other: Placebo
    Sponsor:   Pfizer
    Not yet recruiting - verified November 2009
  • AMG 827 in Rheumatoid Arthritis Subjects With Inadequate Response to Methotrexate

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: AMG 827 140 mg;   Drug: AMG 827 210 mg;   Drug: Placebo;   Drug: AMG 827 70 mg
    Sponsor:   Amgen
    Not yet recruiting - verified November 2009
  • Honeybee Venom Treatment for Osteoarthritis Pain and Inflammation

    Condition:   Osteoarthritis of the Knee
    Intervention:   Drug: honeybee venom (Apitoxin (Korea) Apitox (USA))
    Sponsor:   Apimeds, Inc.
    Recruiting - verified October 2009
  • A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: PF-04171327 10 mg;   Other: Prednisone Placebo;   Drug: PF-04171327 25 mg;   Other: Prednisone Placebo;   Drug: Prednisone 5 mg;   Other: Placebo for PF-04171327;   Other: Placebo;   Other: Placebo for PF-04171327
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Abatacept Versus Adalimumab Head-to-Head

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: Abatacept;   Drug: Adalimumab
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified November 2009
  • Study of Adalimumab in Subjects With Axial Spondyloarthritis

    Condition:   Axial Spondyloarthritis
    Interventions:   Drug: Adalimumab;   Drug: Placebo;   Drug: Open-label Adalimumab
    Sponsor:   Abbott
    Recruiting - verified October 2009
  • Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: LX3305 low dose;   Drug: LX3305 mid dose;   Drug: LX3305 high dose;   Drug: Placebo
    Sponsor:   Lexicon Pharmaceuticals
    Recruiting - verified November 2009
  • INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: INCB028050;   Drug: INCB028050;   Drug: INCB028050;   Drug: Placebo
    Sponsor:   Incyte Corporation
    Recruiting - verified November 2009
  • A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic DMARDs

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: Nonbiologic DMARDs of investigator's choice
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009
  • Study to Evaluate the Safety and Efficacy of ILV-094 in Subjects With Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: ILV-094;   Other: Placebo
    Sponsor:   Wyeth
    Recruiting - verified November 2009
  • Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)

    Condition:   Active Rheumatoid Arthritis
    Interventions:   Drug: Tranilast;   Drug: Tranilast;   Drug: Placebo
    Sponsor:   Nuon Therapeutics, Inc.
    Recruiting - verified October 2009
  • Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab

    Condition:   Juvenile Idiopathic Arthritis
    Intervention:   Drug: Tocilizumab
    Sponsors:   University of Oklahoma;   Hoffmann-La Roche
    Recruiting - verified October 2009
  • Tanezumab and Nerve Function in Arthritis Patients

    Condition:   Osteoarthritis
    Interventions:   Biological: tanezumab;   Biological: tanezumab;   Other: Placebo
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Tanezumab in Osteoarthritis of the Hip or Knee (2)

    Condition:   Osteoarthritis
    Interventions:   Biological: tanezumab 10 mg;   Biological: tanezumab 5 mg;   Drug: naproxen;   Other: placebo
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Periosteal Stimulation for Knee Osteoarthritis

    Condition:   Osteoarthritis, Knee
    Interventions:   Other: Periosteal stimulation;   Other: Control-Periosteal Stimulation
    Sponsor:   Department of Veterans Affairs
    Recruiting - verified October 2009
  • A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for the Treatment of Rheumatoid Arthritis in Patients on Other Background Arthritis Medications

    Condition:   Arthritis, Rheumatoid
    Interventions:   Drug: CP-690,550;   Drug: CP-690,550;   Drug: Placebo;   Drug: Placebo
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Phase 3 Study Comparing 2 Doses of CP-690,550 and the Active Comparator, Humira (Adalimumab) vs. Placebo for Treatment of Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: CP 690,550;   Drug: CP-690,550;   Other: Placebo;   Other: Placebo;   Biological: Biologic TNFi
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate

    Condition:   Arthritis, Rheumatoid
    Interventions:   Drug: CP-690,550;   Drug: CP-690,550;   Drug: CP-690,550;   Drug: CP-690,550;   Drug: Placebo;   Drug: CP-690,550;   Drug: Placebo;   Drug: CP-690,550
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)

    Condition:   Gout
    Interventions:   Biological: Rilonacept;   Other: Placebo
    Sponsor:   Regeneron Pharmaceuticals
    Recruiting - verified October 2009
  • Phase I Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Intravenously Administered Doses of PF-04236921 in Patients With Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: Placebo;   Drug: dose level 1;   Drug: dose level 2;   Drug: dose level 3;   Drug: dose level 4
    Sponsor:   Pfizer
    Recruiting - verified October 2009
  • Infliximab for Treatment of Axial Spondyloarthritis (Study P05336AM1)

    Conditions:   Ankylosing Spondylitis;   Axial Spondyloarthritis
    Interventions:   Drug: infliximab infusion;   Drug: placebo infusion;   Drug: naproxen (Treatment Phase);   Drug: naproxen (Follow-Up Phase);   Other: no intervention (Follow-Up Phase)
    Sponsor:   Schering-Plough
    Recruiting - verified November 2009
  • Tanezumab In Osteoarthritis Of The Knee (2)

    Conditions:   Arthritis;   Osteoarthritis
    Interventions:   Biological: tanezumab 10 mg;   Biological: tanezumab 5 mg;   Drug: naproxen;   Other: placebo
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Post-Market Study of the 3DKnee™ System

    Conditions:   Degenerative Joint Disease;   Osteoarthritis;   Rheumatoid Arthritis;   Traumatic Arthritis
    Intervention:   Device: 3DKnee™ System
    Sponsor:   Encore Medical, L.P.
    Recruiting - verified October 2009
  • A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis

    Condition:   Arthritis, Rheumatoid
    Interventions:   Drug: CP-690,550;   Drug: CP-690,550;   Drug: Placebo;   Drug: Placebo
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: methotrexate;   Drug: placebo
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009
  • Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip

    Conditions:   Osteoarthritis;   Arthritis
    Interventions:   Drug: NSAID;   Biological: tanezumab;   Biological: tanezumab;   Biological: tanezumab;   Drug: NSAID;   Biological: tanezumab;   Drug: NSAID
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • A Phase 4, 6-Week, Randomized Double-Blind, Multicenter, Active-Controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects

    Condition:   Arthritis, Juvenile Rheumatoid
    Interventions:   Drug: Celecoxib;   Drug: Naproxen
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Extension Study Of Tanezumab In Osteoarthritis

    Condition:   Osteoarthritis
    Interventions:   Biological: tanezumab;   Biological: tanezumab;   Biological: tanezumab
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Juvenile Idiopathic Arthritis (JIA) Registry

    Condition:   Juvenile Idiopathic Arthritis
    Interventions:   Drug: adalimumab;   Drug: Methotrexate
    Sponsor:   Abbott
    Recruiting - verified October 2009
  • Active Juvenile Idiopathic Arthritis (JIA)Compassionate Use

    Condition:   Juvenile Idiopathic Arthritis
    Interventions:   Drug: Adalimumab;   Drug: Methotrexate
    Sponsor:   Abbott
    Recruiting - verified October 2009
  • Multiple-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 827 in Subjects With Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Intervention:   Drug: AMG 827
    Sponsor:   Amgen
    Recruiting - verified November 2009
  • Muscle Regrowth During Physical Rehabilitation and Amino Acid Supplementation

    Condition:   Osteoarthritis
    Interventions:   Dietary Supplement: Essential amino acids;   Dietary Supplement: Alanine
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting - verified October 2009
  • Tanezumab in Osteoarthritis Of The Hip

    Conditions:   Arthritis;   Osteoarthritis;   Osteoarthritis, Hip
    Interventions:   Biological: tanezumab;   Biological: tanezumab;   Biological: tanezumab;   Biological: Placebo
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Tanezumab in Osteoarthritis of the Knee

    Conditions:   Arthritis;   Osteoarthritis
    Interventions:   Biological: tanezumab;   Biological: tanezumab;   Biological: tanezumab;   Biological: Placebo
    Sponsor:   Pfizer
    Recruiting - verified November 2009
    • Menu
    Find Paid Clinical Trials